Search

Search Constraints

You searched for: Author/Creator Brand, Randall

Search Results

1. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. (27th February 2017)

2. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. (18th August 2018)

4. Assessment of Nuclear Nanomorphology Marker to Improve the Detection of Malignancy From Bile Duct Biopsy Specimens. Issue 6 (1st June 2014)

5. Correction to: Pain Experience in Pancreatitis: Strong Association of Genetic Risk Loci for Anxiety and PTSD in Patients With Severe, Constant, and Constant-Severe Pain. (4th February 2022)

6. False Biomarker Discovery due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125. (1st February 2014)

7. Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma. Issue 14 (12th April 2019)

9. Identifying Colonic Dysplasia and Cancer From Rectal Nuclear Nano‐morphology Markers in Ulcerative Colitis Patients: 1895. (October 2015)

10. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Issue 1 (10th April 2019)